Cipla To Pour $460 Million Into Production Expansion In India
This article was originally published in PharmAsia News
Executive Summary
India's Cipla says it plans to invest nearly $460 million during the next two years as part of its expansion policy to produce more drugs for domestic and foreign consumption. The funds are to be added to a program already building new facilities and expanding others to take advantage of an anticipated 12 percent to 15 percent growth next year. Part of that growth is expected to be generated by a 10 percent growth in company exports, already comprising half of its business. (Click here for more